Skye Bioscience, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Skye Bioscience, Inc. (SKYE) had Operating Lease, Weighted Average Discount Rate, Percent of 10.75% as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-03-10
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 10.75%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 11.41%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 15.00%.
- 2023-09-30: Operating Lease, Weighted Average Discount Rate, Percent 15.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 10.75% 10-K · filed 2026-03-10 |
| 2024-12-31 | 11.41% 10-K · filed 2025-03-20 |
| 2023-12-31 | 15.00% 10-K · filed 2024-03-22 |
| 2023-09-30 | 15.00% 10-Q · filed 2023-11-14 |
| 2023-06-30 | 15.00% 10-Q · filed 2023-08-07 |
| 2023-03-31 | 12.00% 10-Q · filed 2023-05-12 |
| 2022-12-31 | 12.00% 10-K · filed 2023-03-31 |
| 2022-09-30 | 12.00% 10-Q · filed 2022-11-14 |
| 2022-06-30 | 12.00% 10-Q · filed 2022-08-15 |
| 2022-03-31 | 12.00% 10-Q · filed 2022-05-06 |
| 2021-12-31 | 12.00% 10-K · filed 2022-03-28 |
| 2021-09-30 | 12.00% 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |